NCT06922630

Brief Summary

The WIN intervention aims to improve the mental, social and physical health as well as quality of life of participants with BMI≥30 without focusing on their weight, and with no aim of weight loss. The WIN 6 months intervention is based on the principles and methods of the weight neutral movement Health at Every Size (HAES). The content is developed in a co-design process that involved Danish participants who have lived or professional experiences with such approaches. The intervention uses the method of intuitive eating to align eating behaviours with internal cues of hunger and fullness rather than rules, restrictions and external cues. The intervention also draws on components from Acceptance and Commitment Therapy (ACT) to manage body image concerns and weight stigma.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
8mo left

Started Aug 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress54%
Aug 2025Dec 2026

First Submitted

Initial submission to the registry

April 3, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 10, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

August 7, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

December 4, 2025

Status Verified

November 1, 2025

Enrollment Period

1.4 years

First QC Date

April 3, 2025

Last Update Submit

November 27, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Primary feasibility outcome: completion of follow-up

    The proportion of participants who complete the follow-up examination, defined as answering the 'Mental health component' of the 36-item Short Form survey

    24 weeks after inclusion

Secondary Outcomes (3)

  • Secondary feasibility outcome: recruitment proportion

    Inclusion

  • Secondary feasibility outcome: fidelity midway

    After group session 5 (study week 12)

  • Secondary feasibility outcome: fidelity end of intervention

    After group session 11 (study week 23)

Other Outcomes (39)

  • Exploratory feasibility outcomes: Completion of follow-up, individual questionnaires

    End of study (week 24)

  • Exploratory feasibility outcomes: Completion of follow-up, blood samples

    End of study (week 24)

  • Exploratory feasibility outcomes: Completion of follow-up, hair samples

    End of study (week 24)

  • +36 more other outcomes

Study Arms (1)

WIN

EXPERIMENTAL

Weight-neutral health intervention

Behavioral: WIN

Interventions

WINBEHAVIORAL

Weight-neutral health intervention

WIN

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years old at screening.
  • BMI ≥30 kg/m2.
  • Residence in the Capital Region of Denmark.
  • Able to understand and communicate in Danish.
  • Informed consent.

You may not qualify if:

  • Intends to become pregnant during the intervention or is currently pregnant.
  • Has used weight loss medications or GLP-1 agonist treatment within the past 6 months or intends to use weight loss medications or begin any other intensive weight loss treatment during the WIN intervention.
  • Has severe psychiatric or physical conditions that may interfere with participation or may present a safety concern.
  • Cannot transport themselves to the group sessions.
  • Is deemed unable to complete a two-hour group session, as assessed by the investigator at the clinical screening interview.
  • Takes part in other research involving weight loss treatment that would compromise participation in this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Research Unit for General Practice and Section of General Medicine, Department of Public Health, University of Copenhagen

Copenhagen, Denmark

Location

Related Links

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Carsten Dirksen, Ass. Professor

    Hvidovre University Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 3, 2025

First Posted

April 10, 2025

Study Start

August 7, 2025

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

December 4, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will share

After the results have been published, the aim is to make a depersonalised dataset publicly available on e.g. ClinicalTrials.gov and/or the European Union (EU) Zenodo database (https://zenodo.org/). The final choice will reflect which platform(s) that are compliant with current legislation at that time.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
When the results have been published
Access Criteria
Researchers with a protocol for their planned study

Locations